These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 22797491

  • 1. National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges.
    Bauer D, Krege J, Lane N, Leary E, Libanati C, Miller P, Myers G, Silverman S, Vesper HW, Lee D, Payette M, Randall S.
    Osteoporos Int; 2012 Oct; 23(10):2425-33. PubMed ID: 22797491
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis.
    Vasikaran S, Cooper C, Eastell R, Griesmacher A, Morris HA, Trenti T, Kanis JA.
    Clin Chem Lab Med; 2011 Aug; 49(8):1271-1274. PubMed ID: 21605012
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.
    Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JA, IOF-IFCC Bone Marker Standards Working Group.
    Osteoporos Int; 2011 Feb; 22(2):391-420. PubMed ID: 21184054
    [Abstract] [Full Text] [Related]

  • 7. A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type I procollagen (PINP): a report from the IFCC-IOF Joint Committee for Bone Metabolism.
    Cavalier E, Eastell R, Rye Jørgensen N, Makris K, Tournis S, Vasikaran S, Kanis JA, Cooper C, Pottel H, Morris HA, IFCC-IOF Joint Committee for Bone Metabolism (C-BM).
    Clin Chem Lab Med; 2019 Sep 25; 57(10):1546-1555. PubMed ID: 31085740
    [Abstract] [Full Text] [Related]

  • 8. Chinese bone turnover marker study: reference ranges for C-terminal telopeptide of type I collagen and procollagen I N-terminal peptide by age and gender.
    Li M, Li Y, Deng W, Zhang Z, Deng Z, Hu Y, Xia W, Xu L.
    PLoS One; 2014 Sep 25; 9(8):e103841. PubMed ID: 25117452
    [Abstract] [Full Text] [Related]

  • 9. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
    Shou Z, Jin X, Bian P, Li X, Chen J.
    Geriatr Gerontol Int; 2017 May 25; 17(5):773-778. PubMed ID: 27137883
    [Abstract] [Full Text] [Related]

  • 10. [Significance of Bone Turnover Marker Measurement in the Treatment of Osteoporosis].
    Miura M, Satoh Y.
    Yakugaku Zasshi; 2019 May 25; 139(1):27-33. PubMed ID: 30606924
    [Abstract] [Full Text] [Related]

  • 11. Serum concentrations of formation (PINP) and resorption (Ctx) bone turnover markers in rheumatoid arthritis.
    Wisłowska M, Jakubicz D, Stepień K, Cicha M.
    Rheumatol Int; 2009 Oct 25; 29(12):1403-9. PubMed ID: 19219607
    [Abstract] [Full Text] [Related]

  • 12. Reference intervals for serum concentrations of three bone turnover markers for men and women.
    Michelsen J, Wallaschofski H, Friedrich N, Spielhagen C, Rettig R, Ittermann T, Nauck M, Hannemann A.
    Bone; 2013 Dec 25; 57(2):399-404. PubMed ID: 24076251
    [Abstract] [Full Text] [Related]

  • 13. Bone turnover: Biology and assessment tools.
    Szulc P.
    Best Pract Res Clin Endocrinol Metab; 2018 Oct 25; 32(5):725-738. PubMed ID: 30449551
    [Abstract] [Full Text] [Related]

  • 14.
    Williams C, Sapra A.
    ; 2024 01 25. PubMed ID: 32644732
    [Abstract] [Full Text] [Related]

  • 15. The Utility of Biomarkers in Osteoporosis Management.
    Garnero P.
    Mol Diagn Ther; 2017 Aug 25; 21(4):401-418. PubMed ID: 28271451
    [Abstract] [Full Text] [Related]

  • 16. Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis.
    Lee J, Vasikaran S.
    Ann Lab Med; 2012 Mar 25; 32(2):105-12. PubMed ID: 22389876
    [Abstract] [Full Text] [Related]

  • 17. Contribution of bone turnover markers to the variation in bone mineral density: a study in Vietnamese men and women.
    Nguyen LT, Nguyen UDT, Nguyen TDT, Ho-Pham LT, Nguyen TV.
    Osteoporos Int; 2018 Dec 25; 29(12):2739-2744. PubMed ID: 30196375
    [Abstract] [Full Text] [Related]

  • 18. Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study.
    Bønløkke SE, Rand MS, Haddock B, Arup S, Smith CD, Jensen JEB, Schwarz P, Hovind P, Oturai PS, Jensen LT, Møller S, Eiken P, Rubin KH, Hitz MF, Abrahamsen B, Jørgensen NR.
    Osteoporos Int; 2022 Oct 25; 33(10):2155-2164. PubMed ID: 35729342
    [Abstract] [Full Text] [Related]

  • 19. Current use of bone turnover markers in the management of osteoporosis.
    Brown JP, Don-Wauchope A, Douville P, Albert C, Vasikaran SD.
    Clin Biochem; 2022 Oct 25; 109-110():1-10. PubMed ID: 36096182
    [Abstract] [Full Text] [Related]

  • 20. Study of the distribution by age group of serum cross-linked C-terminal telopeptide of type I collagen and procollagen type I N-propeptide in healthy Japanese women to establish reference values.
    Nomura Y, Yoshizaki A, Yoshikata H, Kikuchi R, Sakakibara H, Chaki O, Fukunaga M, Hirahara F.
    J Bone Miner Metab; 2013 Nov 25; 31(6):644-51. PubMed ID: 23579312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.